Today, MedImmune Specialty Care division of AstraZeneca (MedImmune Specialty Care) announced it has joined with actress Tia Mowry to raise awareness about the importance of an annual flu vaccination. To kick-off the campaign, MedImmune Specialty Care and Mowry unveiled an online video, “I Insist!” (www.YouTube.com/InsistOnTheMist), which uses comedy to educate busy families about the importance of living a healthy lifestyle and making flu vaccination a priority. For Mowry, this includes vaccination with FluMistQuadrivalent, the first and only FDA-approved needle-free flu vaccine for eligible persons 2-49 years old. FluMist Quadrivalent is administered as a gentle mist sprayed into the nose, where the influenza virus usually enters the body.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63079-medimmune-specialty-care-tia-mowry-flumist-quadrivalent-encourage-flu-shot
Today, Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) announced the launch of ‘Cuida tu Don,’ a national public awareness initiative featuring legendary entertainer Mario Kreutzberger, better known as ‘Don Francisco.’ Kreutzberger, who has type 2 diabetes, will serve as an ambassador for the initiative and encourage Hispanics with type 2 diabetes to live a lifestyle conducive to staying healthy. ‘Cuida tu Don,’ translated as ‘Take Care of Your Gift,’ is designed to engage, educate and inspire Hispanics with type 2 diabetes and their families. The initiative provides resources and information in three key aspects of diabetes – nutrition, fitness and treatment options – to the estimated 3.2 million Hispanics in the United States with the disease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7401451-boehringer-ingelheim-diabetes/
In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan.
“For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
Millennium Systems International, creators of Millennium and Meevo salon & spa software, have been busy working on a new initiative to showcase the deep connections consumers have with their hairstylists. “It’s so important to bring to light and recognize the deep connections that we have with our hairstylist,” said Millennium’s Marketing Director, Jen Martinelli. “I personally have been through proms, a wedding day, my daughter and son’s first haircut; all with my hair stylist by my side.”
The campaign starts with a grassroots effort by interviewing real people and real experiences in salons. Its purpose is to bring awareness to everyone, everywhere that beauty professionals play a very significant role in all of our lives. Happy moments, sad moments, and even in moments of feeling lost or confused, hairstylists are the consistent rock making us look and feel beautiful, confident, ready to take on the world. “Confidence is everything. It can mean landing a job, or picking up the pieces after a tragedy, or fighting through an illness,” continues Jen Martinelli. “You can’t buy confidence. Beauty professionals everywhere are making our lives more beautiful… in every sense of that word.”
Millennium Systems International has released its first video of the campaign today and it’s promising to be a tearjerker for everyone. One interviewee talks about the comfort she received from her hair stylist, “when my grandson passed away, when he was seven…. and I called her.”
To view the multimedia release go to:
Kia Motors America (KMA) caused quite a stir with its first-ever Super Bowl ad, which featured a colorful cast of life-size children’s characters in the 2011 Kia Sorento CUV, including Muno from YO GABBA GABBA!, the award-winning children’s television series and live tour. Building on the momentum and increased brand awareness generated by the 60-second spot, KMA plans to extend its relationship with YO GABBA GABBA!, as the presenting sponsor of the upcoming YO GABBA GABBA! THERE’S A PARTY IN MY CITY! tour.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/kia/41953/
Wounded Warrior Project (WWP) in partnership with The PlowShare Group has launched a series of new public service advertisements aimed at raising awareness and enlisting support of the needs of injured service members of the nation’s armed military. Over 40,000 of our nation’s armed forces have been physically wounded during the current military conflicts. Hundreds of thousands more are estimated to be recovering from invisible wounds of war, including post-traumatic stress disorder, major depression, and traumatic brain injury (TBI). WWP assists wounded warriors and their families through a holistic approach to their recovery. Whether through caregiver retreats, combat stress programs, career and education services, or adaptive sporting opportunities, WWP empowers warriors with the tools essential to not just survive their injuries but to thrive and achieve personal and professional success.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/woundedwarriorproject/48587/
In honor of World Pancreatic Cancer Day on Nov. 16, people around the world will come together to Demand Better in the fight against the world’s toughest cancer, starting with earlier diagnosis. The annual one-day campaign is an initiative of the World Pancreatic Cancer Coalition, which is comprised of more than 60 organizations from 27 countries on six continents.
Every day, more than 1,000 people worldwide will be diagnosed with pancreatic cancer. Of that, an estimated 985 will die from the disease. Additionally, pancreatic cancer has the lowest survival rate among all major cancers, and in nearly every country, it is the only major cancer with a single-digit five-year survival rate (2-9 percent). These stunning figures are not merely statistics, they represent family members, friends and colleagues on every corner of the globe.
“This year, we are turning World Pancreatic Cancer Day from a day of awareness to a day of action,” said Julie Fleshman, JD, MBA, World Pancreatic Cancer Coalition chair. “As we expand our global movement to end pancreatic cancer, we are demanding better for pancreatic cancer patients now and in the future.”
To view the multimedia release go to:
More than 173,000 women in the United States are living with metastatic breast cancer and each has a story to tell. AstraZeneca is launching a nationwide photo-sharing campaign to provide them another way to share their inspiration, experiences and strengths with others.
To show their support, women living with metastatic breast cancer can upload photos of themselves on social media using the campaign hashtag #MBCStrength. Photos posted on Twitter by October 1, 2014 and tagged with #MBCStrength will be considered for a Times Square display in New York City on the fifth anniversary of Metastatic Breast Cancer Awareness Day on October 13, 2014.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7305551-mymbcstory-astrazeneca-encourages-women-with-metastatic-breast-cancer-to-share/
www.bms-onkologie.de ist die unternehmensbezogene „Heimat“ von Bristol-Myers Squibb Onkologie und bietet für Fachkreise und Öffentlichkeit seit September 2011 neben einem Einblick in Forschung und Entwicklung auch Aktuelles zu verschiedenen onkologischen Erkrankungen. Herzstück ist eine Mediathek mit multimedialen Inhalten unterteilt in „News“, „Veröffentlichungen“, „Veranstaltungen“ und „Austausch“.
www.melanom-wissen.de ist eine Disease Awareness Website zum Thema Melanom (Schwarzer Hautkrebs). Sie bietet Interessierten umfassende Hinweise zu Risikofaktoren und Prävention sowie hilfreiche Informationen und Serviceangebote nach Diagnosestellung.
In their ongoing effort to keep young children safe, the Window Covering Safety Council and the U.S. Consumer Product Safety Commission have teamed up to remind parents and caregivers that October is National Window Covering Safety Month. This campaign focuses on raising awareness of the potential strangulation hazards that window cords can pose to young children and toddlers. Parents and caregivers are urged to use only cordless window coverings in homes with young children.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52086-october-national-window-covering-safety-month-cords-hazard-children
Wildfires are a serious risk to property and lives in every state in the country. Last year alone the National Interagency Fire Center (NIFC) reported there were 63,212 fires in the U.S. and Puerto Rico that burned 3,595,613 million acres – that’s roughly the size of Connecticut! In an effort to help raise community and homeowner awareness about preparing for wildfires, State Farm and the National Fire Protection Association (NFPA) are working together and encouraging residents to take action during national Wildfire Community preparedness Day.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7452831-state-farm-weather-preparedness/
Jeffrey Bacha, president and CEO of DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) (“DelMar Pharma” or “DelMar”) discusses new clinical research and treatments in development for glioblastoma, the most common and severe form of brain cancer. Less than one out of three patients will survive two years after their diagnosis. DelMar is a cancer-focused company developing new therapies for patients with little to no treatment options.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7037951-delmar-pharmaceuticals-glioblastoma-brain-tumor-awareness-month